ahlam1399
06-29-2016, 06:29 PM
Shire says ADHD drug meets main goal of study
(Reuters) - Irish drugmaker Shire Plc said a study testing an experimental drug to treat attention-deficit disorder met the main goal, bringing the drug one step closer to approval in the United States.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=pyHRnuh3wBM:E38HR7I7BTc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=pyHRnuh3wBM:E38HR7I7BTc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=pyHRnuh3wBM:E38HR7I7BTc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=pyHRnuh3wBM:E38HR7I7BTc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=pyHRnuh3wBM:E38HR7I7BTc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/pyHRnuh3wBM
(Reuters) - Irish drugmaker Shire Plc said a study testing an experimental drug to treat attention-deficit disorder met the main goal, bringing the drug one step closer to approval in the United States.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=pyHRnuh3wBM:E38HR7I7BTc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=pyHRnuh3wBM:E38HR7I7BTc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=pyHRnuh3wBM:E38HR7I7BTc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=pyHRnuh3wBM:E38HR7I7BTc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=pyHRnuh3wBM:E38HR7I7BTc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/pyHRnuh3wBM